2D nanoconfinement distorts the solvation structure of hydroxide but not of hydronium
Faraday Discussions · 2026 · 266 · 96-112
DOI: 10.1039/d5fd00126a ↗Kurz gefasst
Fachartikel in der Zeitschrift Faraday Discussions, 2026. Verfasst von Margaret L Berrens und 3 weiteren Autor:innen. Beteiligte Einrichtung: Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA. berrens1@llnl.gov. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Basic Energy Sciences, Lawrence Livermore National Laboratory.
Abstract (Originalsprache)
Pictorial representation of how hydronium is able to retain its bulk-like hydrogen bonding structure under confinement between hexagonal boron nitride sheets, while hydroxide remains under coordinated.
Autor:innen und Institutionen
- Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory, Livermore, California 94550, USA. berrens1@llnl.gov.
- Department of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, California 95064, USA. mcalegar@ucsc.edu.
Förderung
- Basic Energy Sciences
- Lawrence Livermore National Laboratory
Zitieren
APA
Berrens, M. L., Calegari Andrade, M. F., Pham, C. H., & Pham, T. A. (2026). 2D nanoconfinement distorts the solvation structure of hydroxide but not of hydronium. Faraday Discussions, 266, 96-112. https://doi.org/10.1039/d5fd00126a
Vancouver
Berrens ML, Calegari Andrade MF, Pham CH, Pham TA. 2D nanoconfinement distorts the solvation structure of hydroxide but not of hydronium. Faraday Discussions. 2026;266:96-112. doi:10.1039/d5fd00126a
BibTeX
@article{Berrens2026,
author = {Berrens, Margaret L and Calegari Andrade, Marcos F and Pham, C Huy and Pham, Tuan Anh},
title = {2D nanoconfinement distorts the solvation structure of hydroxide but not of hydronium},
journal = {Faraday Discussions},
year = {2026},
volume = {266},
pages = {96--112},
doi = {10.1039/d5fd00126a}
}
EUVIMED